Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet
- PMID: 9420039
- PMCID: PMC164189
- DOI: 10.1128/AAC.41.12.2686
Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet
Abstract
We established a quantitative flow cytometric method for determination of herpes simplex virus type 1 (HSV-1) susceptibility to acyclovir (ACV), ganciclovir, and foscarnet in vitro. Susceptibility was defined in terms of the drug concentration which reduced the number of cells expressing HSV-1 glycoprotein C (gpC) with a fluorescence intensity of > or =10(2) by 50% (IC50). Flow cytometry allowed us to use a high (1.0) as well as a low (0.005) multiplicity of infection, and determination of the IC50 was possible after one or more viral replicative cycles. IC50s were dependent on virus input and on time postinfection. In mixture experiments, 1 to 2% resistant viruses added to a sensitive strain could be detected. The results obtained by flow cytometry showed a good qualitative correlation with those achieved by cytopathic effect inhibitory assay. However, flow cytometry might detect more quantitative differences in drug susceptibility, especially among resistant strains, as confirmed also by determination of intracellular drug phosphorylation. The mean IC50s for ACV-sensitive strains were 0.45 to 1.47 microM, and those for ACV-resistant strains were between 140 and 3,134 microM. Flow cytometric analysis was fast and accurate, automatizable, and highly reproducible. Flow cytometry may be a more powerful tool than standard cytopathic effect-based assays and could have advantages for the detection of low levels of drug resistance or mixtures of sensitive and resistant virus strains.
Similar articles
-
Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents.J Antimicrob Chemother. 1999 Nov;44(5):705-8. doi: 10.1093/jac/44.5.705. J Antimicrob Chemother. 1999. PMID: 10552991
-
Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.J Med Virol. 2002 Sep;68(1):99-104. doi: 10.1002/jmv.10175. J Med Virol. 2002. PMID: 12210436
-
Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.Antiviral Res. 2006 Mar;69(3):152-7. doi: 10.1016/j.antiviral.2005.11.004. Epub 2005 Dec 19. Antiviral Res. 2006. PMID: 16388859
-
Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.J Hosp Infect. 1996 Aug;33(4):235-48. doi: 10.1016/s0195-6701(96)90010-9. J Hosp Infect. 1996. PMID: 8864937 Review.
-
Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection.J Pediatr Pharmacol Ther. 2014 Apr;19(2):72-82. doi: 10.5863/1551-6776-19.2.72. J Pediatr Pharmacol Ther. 2014. PMID: 25024666 Free PMC article. Review.
Cited by
-
Use of a single monoclonal antibody to determine the susceptibilities of herpes simplex virus type 1 and type 2 clinical isolates to acyclovir.Clin Diagn Lab Immunol. 2002 Nov;9(6):1379-81. doi: 10.1128/cdli.9.6.1379-1381.2002. Clin Diagn Lab Immunol. 2002. PMID: 12414779 Free PMC article.
-
A core extended naphtalene diimide G-quadruplex ligand potently inhibits herpes simplex virus 1 replication.Sci Rep. 2017 May 24;7(1):2341. doi: 10.1038/s41598-017-02667-3. Sci Rep. 2017. PMID: 28539620 Free PMC article.
-
Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity.J Virol. 2000 Nov;74(22):10729-36. doi: 10.1128/jvi.74.22.10729-10736.2000. J Virol. 2000. PMID: 11044117 Free PMC article.
-
The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.J Virol. 2010 May;84(9):4534-42. doi: 10.1128/JVI.02487-09. Epub 2010 Feb 24. J Virol. 2010. PMID: 20181711 Free PMC article.
-
Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.J Clin Microbiol. 2004 Jan;42(1):242-9. doi: 10.1128/JCM.42.1.242-249.2004. J Clin Microbiol. 2004. PMID: 14715760 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources